Biotech
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 11/01/12 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies announced today ...
PRINCETON, NJ: High Patch Compliance Not Affected by Age, Race, or Education ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 11/01/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September 30, 2012. The Company had $148.3 mil ...
CARY, NC: CARY, NC -- (Marketwire) -- 11/01/12 -- Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and related specialty mar ...
SAN DIEGO, CA: Early Evidence of Efficient Virotherapeutic Replication and Cancer Cell Lysis in GL-ONC1 Treated Patients ...
MIAMI, FL: MIAMI, FL -- (Marketwire) -- 11/01/12 -- Progressive Care Inc. (OTCBB: RXMD) (OTCQB: RXMD) and its subsidiary, PharmCo, LLC, ("PharmCo"), a provider of prescription pharmaceuticals, special ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 10/31/12 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the t ...
PORT HUENEME, CA: PORT HUENEME, CA -- (Marketwire) -- 10/31/12 -- Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leade ...
BERKELEY, CA: $6 Million Payment From AstraZeneca Due to Dynavax ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 10/31/12 -- MethylGene Inc. (TSX: MYG) today announced that preclinical data for its clinical-stage Met/VEGFR inhibitor MGCD265, will be presented at the 24th EOR ...
TUSTIN, CA: Presentation at the 27th Annual Meeting of the Society for Immunotherapy of Cancer Highlights Ability of PS-Targeting Antibodies to Induce Innate and Adaptive Immune Responses; Published Article in Nu ...
PISCATAWAY, NJ: PISCATAWAY, NJ -- (Marketwire) -- 10/31/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced its financial results for the third quarter of 2012. Enzon reported net income of $4.2 million ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwire) -- 10/31/12 -- Cytovance Biologics, Inc. and Fountain BioPharma, Inc. jointly announce the execution of a Biopharmaceutical Development and Manufacturing collaborati ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/30/12 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce yesterday's successful ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 10/30/12 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) today announced its revised business plan which will focus on revenue growth from tesamorelin in the s ...
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 10/30/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its third quarter 2012 financial results will be released on Tuesday, November 13, 2012. Followin ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 10/29/12 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (TSX VENTURE: BMR.H) today announced its third quarter 2012 operational ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 10/29/12 -- Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) announced today that its wholly owned subsidiary, Regen BioPharma, Inc., will be presenting today at the 2 ...
LEXINGTON, KY: LEXINGTON, KY -- (Marketwire) -- 10/29/12 -- Eric W. Smart has been named the new President and CEO of , the largest sterile pharmaceutical manufacturing facility in Kentucky.Smart brings to Coldstre ...
